PWMG
KRYS icon

Private Wealth Management Group’s Krystal Biotech KRYS Stock Holding History

Private Wealth Management Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Hold
55
– – ﹤0.01% 378
2026
Q1 		$14.2K Hold
55
– – ﹤0.01% 425
2025
Q4 		$13.6K Hold
55
– – ﹤0.01% 424
2025
Q3 		$9.71K Hold
55
– – ﹤0.01% 517
2025
Q2 		$7.56K Buy
55
+50
+1,000% +$7.34K ﹤0.01% 587
2025
Q1 		$902 Hold
5
– – ﹤0.01% 1297
2024
Q4 		$784 Hold
5
– – ﹤0.01% 1352
2024
Q3 		$911 Hold
5
– – ﹤0.01% 1309
2024
Q2 		$919 Hold
5
– – ﹤0.01% 1311
2024
Q1 		$890 Hold
5
– – ﹤0.01% 1298
2023
Q4 		$621 Buy
+5
New +$554 ﹤0.01% 1412

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Wealth Management Group's KRYS Position: Q2 2026 in Review

Private Wealth Management Group held its Krystal Biotech (KRYS) position steady in Q2 2026 at 55 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Private Wealth Management Group first reported a position in KRYS in Q4 2023 and has held it in 11 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Private Wealth Management Group held 55 shares of Krystal Biotech worth $20.4K as of Q2 2026.
  • Private Wealth Management Group left its Krystal Biotech share count unchanged in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #378 holding.
  • Private Wealth Management Group first reported a position in Krystal Biotech in Q4 2023 and has held it in 11 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.